Molecular genetics of acute myeloid leukemia

Paolo Bernasconi, Marina Boni, Paola Maria Cavigliano, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Marilena Caresana

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recurring chromosomal abnormalities are detected in most patients with acute myeloid leukemia (AML). They may be associated with a distinct AML FAB subtype or may identify distinct clinicobiological entities within the same FAB subtype. Therefore, cytogenetic investigation has a pivotal role in AML diagnosis. In addition, it is one of the most valuable prognostic determinants of the disease, as recently demonstrated. The development of new molecular techniques, such as reverse transcriptase polymerase chain reaction and fluorescence in situ hybridization, has allowed perfect definition of the chromosome regions containing genes with a crucial role in normal hemopoiesis and leukemia. Understanding the action of such genes provides new insights into AML pathogenesis and has led us to envisage new therapeutic options.

Original languageEnglish
Pages (from-to)297-305
Number of pages9
JournalAnnals of the New York Academy of Sciences
Volume963
Publication statusPublished - 2002

Fingerprint

Acute Myeloid Leukemia
Molecular Biology
Genes
Polymerase chain reaction
RNA-Directed DNA Polymerase
Chromosomes
Fluorescence
Reverse Transcriptase Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Cytogenetics
Chromosome Aberrations
Leukemia
Genetics
Gene
Molecular Genetics
Entity
In Situ
Hybridization
Chromosome
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Chromosomal abnormalities
  • FAB subtype
  • Genetics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Molecular genetics of acute myeloid leukemia. / Bernasconi, Paolo; Boni, Marina; Cavigliano, Paola Maria; Calatroni, Silvia; Giardini, Ilaria; Rocca, Barbara; Caresana, Marilena.

In: Annals of the New York Academy of Sciences, Vol. 963, 2002, p. 297-305.

Research output: Contribution to journalArticle

Bernasconi, Paolo ; Boni, Marina ; Cavigliano, Paola Maria ; Calatroni, Silvia ; Giardini, Ilaria ; Rocca, Barbara ; Caresana, Marilena. / Molecular genetics of acute myeloid leukemia. In: Annals of the New York Academy of Sciences. 2002 ; Vol. 963. pp. 297-305.
@article{935eee5c548649bf8565cecfbd5cc6ee,
title = "Molecular genetics of acute myeloid leukemia",
abstract = "Recurring chromosomal abnormalities are detected in most patients with acute myeloid leukemia (AML). They may be associated with a distinct AML FAB subtype or may identify distinct clinicobiological entities within the same FAB subtype. Therefore, cytogenetic investigation has a pivotal role in AML diagnosis. In addition, it is one of the most valuable prognostic determinants of the disease, as recently demonstrated. The development of new molecular techniques, such as reverse transcriptase polymerase chain reaction and fluorescence in situ hybridization, has allowed perfect definition of the chromosome regions containing genes with a crucial role in normal hemopoiesis and leukemia. Understanding the action of such genes provides new insights into AML pathogenesis and has led us to envisage new therapeutic options.",
keywords = "Acute myeloid leukemia, Chromosomal abnormalities, FAB subtype, Genetics",
author = "Paolo Bernasconi and Marina Boni and Cavigliano, {Paola Maria} and Silvia Calatroni and Ilaria Giardini and Barbara Rocca and Marilena Caresana",
year = "2002",
language = "English",
volume = "963",
pages = "297--305",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Molecular genetics of acute myeloid leukemia

AU - Bernasconi, Paolo

AU - Boni, Marina

AU - Cavigliano, Paola Maria

AU - Calatroni, Silvia

AU - Giardini, Ilaria

AU - Rocca, Barbara

AU - Caresana, Marilena

PY - 2002

Y1 - 2002

N2 - Recurring chromosomal abnormalities are detected in most patients with acute myeloid leukemia (AML). They may be associated with a distinct AML FAB subtype or may identify distinct clinicobiological entities within the same FAB subtype. Therefore, cytogenetic investigation has a pivotal role in AML diagnosis. In addition, it is one of the most valuable prognostic determinants of the disease, as recently demonstrated. The development of new molecular techniques, such as reverse transcriptase polymerase chain reaction and fluorescence in situ hybridization, has allowed perfect definition of the chromosome regions containing genes with a crucial role in normal hemopoiesis and leukemia. Understanding the action of such genes provides new insights into AML pathogenesis and has led us to envisage new therapeutic options.

AB - Recurring chromosomal abnormalities are detected in most patients with acute myeloid leukemia (AML). They may be associated with a distinct AML FAB subtype or may identify distinct clinicobiological entities within the same FAB subtype. Therefore, cytogenetic investigation has a pivotal role in AML diagnosis. In addition, it is one of the most valuable prognostic determinants of the disease, as recently demonstrated. The development of new molecular techniques, such as reverse transcriptase polymerase chain reaction and fluorescence in situ hybridization, has allowed perfect definition of the chromosome regions containing genes with a crucial role in normal hemopoiesis and leukemia. Understanding the action of such genes provides new insights into AML pathogenesis and has led us to envisage new therapeutic options.

KW - Acute myeloid leukemia

KW - Chromosomal abnormalities

KW - FAB subtype

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=0036291343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036291343&partnerID=8YFLogxK

M3 - Article

C2 - 12095955

AN - SCOPUS:0036291343

VL - 963

SP - 297

EP - 305

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -